期刊文献+

黄精益阴汤对老年高血压患者血压、血脂及肝肾功能的作用观察 被引量:1

The influence of the Huangjing Yiyin decoction on blood pressure, blood lipid and function of liver and kidney in elderly patients with hypertension
下载PDF
导出
摘要 目的:研究分析黄精益阴汤对老年高血压患者血压、血脂和肝肾功能的影响。方法:选取老年高血压患者82例,将其随机分为两组,各41例。对照组予硝苯地平缓释片治疗,观察组予黄精益阴汤治疗,对比两组血压、血脂和肝肾功能情况。结果:观察组收缩压、舒张压明显低于对照组,差异显著(P<0.05);观察组ALT高于对照组,差异显著(P<0.05);观察组TC、TG明显低于对照组,差异显著(P<0.05);观察组总有效率明显优于对照组,差异显著(P<0.05)。结论:黄精益阴汤治疗老年高血压患者效果显著,可降低血压、血脂水平,改善肝肾功能,值得推广。 Objective: The influence of the Huangjin Yiyin decoction on blood pressure, blood lipid and fimction of liver and kidney in elderly patients with hypertension was researched. Methods: 82 cases were selected and randomized into 2 groups, 41 cases in each. The control group was given nifedipine retard. The observed group took the Huangjin Yiyin decoction. Blood pressure, blood lipid and function of liver and kidney in groups were compared. Results: Systolic blood pressure and diastolic blood pressure in the observed group were evidently lower than those in the control group, with a significant difference. ALT in the observed group was higher than that in the control group (P〈0.05). TC, TG in the observed group were obviously lower than those in the control group (P〈0.05). The total efficiency in the observed group was obviously better (P〈0.05). Conclusion: The Huangjing Yiyin decoction on elderly hypertension gained marked effects, by reducing levels of blood pressure and blood lipid, could improve liver and kidney functions, and was worthy of clinical application.
出处 《中医临床研究》 2016年第29期69-70,共2页 Clinical Journal Of Chinese Medicine
关键词 黄精益阴汤 老年高血压 血压 血脂 肝肾功能 The Huangjing Yiyin decoction Elderly hypertension Blood pressure Blood lipid Liver and kidney functions
  • 相关文献

参考文献4

二级参考文献27

  • 1李友元,邓洪波,向大雄,陈珑珑.黄精多糖的降血脂及抗动脉粥样硬化作用[J].中国动脉硬化杂志,2005,13(4):429-431. 被引量:76
  • 2中国高血压防治指南修订委员会.中国高血压防治指南[S].北京:人民卫生出版社,2005.
  • 3Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for anglogenesis[J]. Science, 1997,275 : 964-967.
  • 4Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells[J]. Blood, 1998, 15:362-367.
  • 5Keymel S, Kalka C, Rassaf T, et al. Impaired endothelial progenitor cell function predicts age- dependent carotid intimal thickening]-J~. Basic Res in Cardiol, 2008,103 ; 582-586.
  • 6Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease]-J~. Cir Res, 2001, 89: el-e7.
  • 7Peichev M,Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursorsrJ~. Blood, 2000,95 : 952 958.
  • 8Fadini GP, Coracina A, Baesso I, et al. Peripheral blood CD34+ KDR-u endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general populationFJ~. Stroke, 2006,37 : 2277 2282.
  • 9Sutherland DR, Anderson L, keeney M, et al. The ISHAGE guidelines for CD34-1- cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering ~- J ~ . J Hematother, 1996,5 : 213-226.
  • 10Boilson BA, Kiernan TJ, Harbuzariu A, et al.Circulating CD34 + cell subsets in patients with coronary endothelial dysfunction [J]. Nat Clin Pract Cardiovasc Med, 2008 ,5:489-496.

共引文献14

同被引文献46

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部